Co-Diagnostics
CODX
36 hedge funds and large institutions have $5.52M invested in Co-Diagnostics in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 10 closing their positions.
105% more call options, than puts
Call options by funds: $150K | Put options by funds: $73K
0.03% less ownership
Funds ownership: 0.49% → 0.46% (-0.03%)
5% less capital invested
Capital invested by funds: $5.81M → $5.52M (-$287K)
16% less funds holding
Funds holding: 43 → 36 (-7)
55% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 11
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$56.5K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$17.5K |
| 3 |
CPA
Capital Performance Advisors
Walnut Creek,
California
|
+$5.11K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.99K |
| 5 |
BlackRock
New York
|
+$3.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Simplex Trading
Chicago,
Illinois
|
-$69.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$36.3K |
| 3 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$28.1K |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
-$27.8K |
| 5 |
TC
TownSquare Capital
Provo,
Utah
|
-$25K |
CODX Hedge Fund Activity: Q3 2024 in Review
36 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q3 2024, worth a combined $5.52M — down 4.9% from $5.81M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of CODX and 3 opened new positions — a net loss of 7 holders — while 11 trimmed existing stakes and 5 added.
The largest buyer was Jane Street, opening a new position worth an estimated $56.5K. The largest seller was Simplex Trading, cutting an estimated $69.2K.
- 36 institutional investors held Co-Diagnostics (CODX) as of Q3 2024, down from 43 in Q2 2024.
- Funds reported $5.52M of Co-Diagnostics stock for Q3 2024, down 4.9% quarter-over-quarter.
- 3 funds opened new Co-Diagnostics positions in Q3 2024 and 10 closed out, a net change of -7 holders.
- The largest Co-Diagnostics buyer in Q3 2024 was Jane Street, an estimated $56.5K added.
- The largest Co-Diagnostics seller in Q3 2024 was Simplex Trading, an estimated $69.2K sold.
Based on aggregated 13F filings for Q3 2024.